Compare RGR & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RGR | PACB |
|---|---|---|
| Founded | 1949 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ordnance And Accessories | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 601.9M | 521.8M |
| IPO Year | 1994 | 2010 |
| Metric | RGR | PACB |
|---|---|---|
| Price | $43.56 | $2.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $43.00 | $2.40 |
| AVG Volume (30 Days) | 216.8K | ★ 13.0M |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.05% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.44 | N/A |
| Revenue | ★ $546,057,000.00 | $93,468,000.00 |
| Revenue This Year | $6.89 | N/A |
| Revenue Next Year | $1.61 | $15.58 |
| P/E Ratio | $99.11 | ★ N/A |
| Revenue Growth | 1.94 | ★ 3.04 |
| 52 Week Low | $28.33 | $1.07 |
| 52 Week High | $48.21 | $3.44 |
| Indicator | RGR | PACB |
|---|---|---|
| Relative Strength Index (RSI) | 66.12 | 62.97 |
| Support Level | $36.79 | $1.27 |
| Resistance Level | $44.00 | $2.73 |
| Average True Range (ATR) | 0.87 | 0.27 |
| MACD | 0.07 | 0.06 |
| Stochastic Oscillator | 66.75 | 47.09 |
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States, and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.